An AluYa5 Insertion in the 3′UTR of COL4A1 and Cerebral Small Vessel Disease
Authors:
Open Access
- 1 April 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (4) , e247034
Abstract
Importance: Cerebral small vessel diseases (CSVDs) account for one-fifth of stroke cases. Numerous familial cases remain unresolved after routine screening of known CSVD genes.Objective: To identify novel genes and mechanisms associated with familial CSVD.Design, Setting, and Participants: This 2-stage study involved linkage analysis and a case-control study; linkage analysis and whole exome and genome sequencing were used to identify candidate gene variants in 2 large families with CSVD (9 patients with CSVD). Then, a case-control analysis was conducted on 246 unrelated probands, including probands from these 2 families and 244 additional probands. All probands (clinical onset COL4A1 3′UTR in the 2 large families with CSVD. Reverse transcriptase–quantitative polymerase chain reaction (RT-qPCR), Western blot, and long-read RNA sequencing were used to investigate outcomes associated with the insertion using patient fibroblasts. Clinical and magnetic resonance imaging features of probands with variants and available relatives were assessed.Results: Among 246 probands (141 females [57.3%]; median [IQR] age at referral, 56 [49-64] years), 7 patients of French ancestry carried the insertion. This insertion was absent in 467 healthy French individuals in a control group (odds ratio, ∞; 95% CI, 2.78 to ∞; P = 5 × 10−4) and 10 847 individuals from the gnomAD structural variant database (odds ratio, ∞; 95% CI, 64.77 to ∞; P = 2.42 × 10−12). In these 7 patients’ families, 19 family members with CSVD carried the insertion. RT-qPCR and Western blot showed an upregulation of COL4A1 mRNA (10.6-fold increase; 95% CI, 1.4-fold to 17.1-fold increase) and protein levels (2.8-fold increase; 95% CI, 2.1-fold to 3.5-fold increase) in patient vs control group fibroblasts. Long-read RNA sequencing data showed that the insertion was associated with perturbation in the use of canonical COL4A1 polyadenylation signals (approximately 87% of isoforms transcribed from the wild type allele vs 5% of isoforms transcribed from the allele with the insertion used the 2 distal canonical polyadenylation signals). The main clinical feature of individuals with CSVD was the recurrence of pontine ischemic lesions starting at an early age (17 of 19 patients [89.5%]).Conclusions and relevance: This study found a novel mechanism associated with COL4A1 upregulation and a highly penetrant adult-onset CSVD. These findings suggest that quantitative alterations of the cerebrovascular matrisome are associated with CSVD pathogenesis, with diagnostic and therapeutic implications.Keywords
This publication has 27 references indexed in Scilit:
- Context-specific regulation and function of mRNA alternative polyadenylationNature Reviews Molecular Cell Biology, 2022
- Cleavage stimulating factor 64 depletion mitigates cardiac fibrosis through alternative polyadenylationBiochemical and Biophysical Research Communications, 2022
- Alternative polyadenylation of mRNA and its role in cancerGenes & Diseases, 2021
- Widespread transcript shortening through alternative polyadenylation in secretory cell differentiationNature Communications, 2020
- A structural variation reference for medical and population geneticsNature, 2020
- Mechanistic insights into mRNA 3′-end processingCurrent Opinion in Structural Biology, 2019
- Multi-infarct dementia of Swedish type is caused by a 3’UTR mutation of COL4A1Brain, 2017
- HeterozygousHTRA1mutations are associated with autosomal dominant cerebral small vessel diseaseBrain, 2015
- Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain?Journal of Cerebral Blood Flow & Metabolism, 2015
- Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementiaNature, 1996